1Propst T, Propst A, Herold M, et al. High levels of interleukin 6 and its secondary mediators in spontaneous bacterial peritonitis [ J ]. Gastroenterology, 1993, 105 (1): 310.
3Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause Of invasive cervical cancer worldwide[J] . J Pathol, 1999, 189 (1): 12.
5Chao A, Lin CT, Hsueh S, et al. Usefulness of human papillomavirus testing in the follow - up of patients with high - grade cervical intraepithelial neoplasia after conization [ J] . Am J Obstet Gynecol, 2004, 190 (4): 1046.
6Zielinski GD, Rozendaal L, Voorhorst FJ, et al. HPV testing can reduce the number of follow - up visits in woman treated for cervical intraepithelial neoplasia grade 3 [J] . Gynecol Oncol, 2003, 91 ( 1 ) : 63.
7Costa S, De Simone P, Venturoli S, et al. Factors predicting human papillomavirus clearance in cervical intraepithelial neoplasia lesions treated by conization [J] . Gynecol Oncol, 2003, 90 (1) : 358.
9Mutirangura A, Sriuranpong V, Termrunggraunglert W, et al. Telomerase activity and human papillomavirus in malignant, premalignant and benign cervical lesions[ J]. Br J Cancer,1998,78(7) :933.
5Soner Altiok,PhD,et al.Molecular markers in cervical cytology[J].Clin Lab Med,2003,(23):709-728.
6Carrillo A, Mohar A, Meneses A,et al. Usefulness of combining universal oligonucleotides in detecting human papillomavirus in cervical cancer and premalignant lesions[J]. Salud Publica Mex,2004,46(1):7-15.
7Josefsson A,Magnusson PKE,Ylitalo N,et al.Viral load of human papillomavirus16 as a determinant for development of cervical carcinoma in situ:a nested case-control study[J].Lancet,2000,355(9222):2189-93.
8Zur Hausen H.Papillomavirus caueing cancer:evasion from host-cell control in early events in carcinogenesis[J].J Natl Cancer Inst,2000,92(9) :690-8.
9Saranath D,Khan Z,Tandle A,et al.HPV16/18 prevalence in cervical lesions/cancers and p53 genoypes in cervical cancer patients form India[J].Gynecol Oncol,2002,86(2):157-62.
10Munger K,Scheffner M,Huibregtse JM,et al.Interactions of HPV E6 and E7 oncoproteins with tumour suppressor gene products[J].Cancer Surv,1992,12:197-217.
1de Cremonx P, de la Rochefordiere A, Savignoni A,et al. Different out- come of invasive cervical cancer associated with high-risk, versus inter- mediate-risk HPV genotype[J]. Int J Cancer,2009,124(4) :778-782.
2Houfflin Debarge V, Collinet P, Vinatier D, etal. Value of human papillomavirus testing after conization by loop electrosurgical excision for high-grade squamous intraepithelial lesions [ J ]. Gynecol Oncol, 2003,90(3 ) :587-592.
3Rome RM,England PG. Management of vaginal intraepithehlial ne- piasia: a series of 132 eases with Iong-time follow-up[J].Int J Gyne- col Cancer,2000,10 ( 5 ) :382-390.
5Nabi G.Knowledge of Saudi female university students regarding cervicalcancerand acceptance of the human papillomavirus.Saudi Med J,2015,36:254-256.
6Adejuyigbe FF,Balogun MR,Balogun BR,et al.Cervical Cancer and Human Papilloma Virus Knowledge and Acceptance of Vaccination among Medical Students in Southwest Nigeria.Afr J Reprod Health,2015,19:140-148.
7Yu MC,Austin RM,Lin J,et al.The Role of High-Risk Human Papilloma Virus Testing in the Surveillance of Cervical Cancer After Treatment.Arch Pathol Lab Med,2015,139:1437-1440.
